Resmed Inc. RMD

NYS: RMD | ISIN: US7611521078 30/04/2025

236,59 USD (-0,48%)

(-0,48%) 30/04/2025

Grafiek Resmed Inc.

Grafiek Resmed Inc.

1 dag1d -0,48%
1 week1w 0,21%
1 maand1m 6,43%
3 maanden3m -1,65%
6 maanden6m -3,15%
1 jaar1j 10,04%
5 jaar5j 48,73%

Resmed Inc. in het nieuws

Toon enkel gratis nieuws

21 april 2025 · Resmed Names Salli Schwartz as Chief Investor Relations Officer · Persbericht

19 maart 2025 · New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer · Persbericht

11 maart 2025 · Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution · Persbericht

26 februari 2025 · ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep · Persbericht

10 september 2024 · Vaping Expected to Increase COPD Health and Economic Burden by 2050 · Persbericht

10 juni 2024 · PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia · Persbericht

15 maart 2024 · ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis · Persbericht

9 november 2023 · ResMed Adopts New Operating Model to Accelerate Long-term Growth · Persbericht

6 oktober 2023 · Thinking about trading options or stock in Apple, Super Micro Computer, Pioneer Natural Resources, Shoals Technologies Group, or Resmed? · Persbericht

5 juli 2023 · ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software · Persbericht

Profiel Resmed Inc.

Gezondheidstechnologie

Medische Specialiteiten

Productie van medische instrumenten

Website: www.resmed.com

Hoofdzetel: San Diego, California Verenigde Staten

CEO: Michael Farrell

Werknemers: 5.138

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe